Načítá se...
Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha
Cancer is one of the main causes of human mortality worldwide and novel chemotherapeutics are required due to the limitations of conventional cancer therapies. For example, using redox selenium compounds as novel chemotherapeutics seem to be very promising. The objective of this study was to explore...
Uloženo v:
| Vydáno v: | Heliyon |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209087/ https://ncbi.nlm.nih.gov/pubmed/34169173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2021.e07254 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|